Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$10.57 USD
+0.45 (4.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.53 -0.04 (-0.38%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Earnings News For INO
-
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
-
Inovio: Q3 Earnings Snapshot
-
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
-
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
-
Inovio: Q2 Earnings Snapshot
-
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates
-
Inovio: Q1 Earnings Snapshot
-
INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights
-
Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates
-
INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights
-
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates
-
Inovio: Q3 Earnings Snapshot
-
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022
-
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
-
Inovio: Q2 Earnings Snapshot
-
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Lags Revenue Estimates
-
Inovio Pharmaceuticals (INO) Reports Q4 Loss, Tops Revenue Estimates
-
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates
-
Analysts Estimate Inovio Pharmaceuticals (INO) to Report a Decline in Earnings: What to Look Out for
-
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Misses Revenue Estimates
-
Analysts Estimate Inovio Pharmaceuticals (INO) to Report a Decline in Earnings: What to Look Out for
-
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates
-
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?